NIH-funded research R01 grant

Understanding Migraine Changes in Teenagers

Official title: Migraine Prognosis in Adolescents

Funded at Washington University · NIH-11127434 · Data updated 2026-11-12

This project aims to understand why migraine symptoms change in teenagers during puberty, helping us predict who might get better or worse.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$615,382
NIH project number5R01NS134986-02
Project IDNIH-11127434 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adolescents aged 10-13 with episodic migraine who have had migraine onset more than six months ago.

Less likely to help

Patients who do not experience migraine or are outside the specified age range would not directly benefit from this particular research.

What this research studies

Migraine affects many children and adolescents, and symptoms can change during puberty, with some experiencing more headaches and others fewer. Currently, we can't predict if a teenager's migraines will improve, stay the same, or worsen over time. This project looks for factors like hormone levels (specifically testosterone), how the body handles pain, and brain activity in areas like the amygdala that might predict these changes. Researchers will follow adolescents with migraine to see how these factors relate to their headache frequency over time. The goal is to discover the underlying reasons for these changes and identify early signs of improvement or worsening.

Why it matters

Potential benefit: If successful, this work could help doctors predict how a teenager's migraines will evolve and offer more personalized treatment plans.

How similar studies have gone: Preliminary data suggests that factors like testosterone levels, pain modulation, and brain activity may predict migraine changes, indicating a promising direction for this novel approach.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Nahman-Averbuch, Hadas — Washington University
  • Study coordinator: Nahman-Averbuch, Hadas

Related research

Other NIH-funded projects on the same topics.

  • Migraine prognosis in adolescents

    This study follows adolescents with migraine to understand why some get better, worse, or stay the same over puberty and what neural, hormonal, and psychological factors influence those changes.

    NIH research Washington University · Saint Louis, United States · NIH-11365079

  • Understanding how puberty affects migraines in adolescents

    This study is looking at how different things, like hormones and emotions, affect migraines in kids aged 10 to 13 during puberty, to help us understand why their headaches might change over time.

    NIH research Washington University · Saint Louis, United States · NIH-10981169

  • Colorectal cancer prognosis through a broad, collaborative study

    A large, multi-center study follows people newly diagnosed with colorectal cancer to find biomarkers and patterns that predict outcomes and guide future care.

    NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11590756

  • AI-powered digital pathology to tailor cancer treatment decisions

    A team at Emory is building an AI-powered platform that analyzes cancer slides to help doctors choose the right therapies and avoid unnecessary chemotherapy or radiation for patients.

    NIH research Emory University · Atlanta, United States · NIH-11535321

  • Harnessing the body's response to leptospirosis to aid diagnosis and prognosis

    This grant aims to develop new ways to detect leptospirosis earlier and predict how severe it might become by studying the body's own response.

    NIH research University of California Los Angeles · Los Angeles, United States · NIH-11535302

  • Harnessing the body’s response to Leptospirosis to improve diagnosis and prognosis

    A research program at UCLA aims to use how the body responds to leptospirosis to make better diagnoses and predict outcomes for patients.

    NIH research University of California Los Angeles · Los Angeles, United States · NIH-11535277

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.